Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Binder, C.
Right arrow Articles by Einspanier, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binder, C.
Right arrow Articles by Einspanier, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 8, No. 9, 789-796, September 2002
© 2002 European Society of Human Reproduction and Embryology


Reproductive endocrinology

Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases

C. Binder1,3, Th. Hagemann1, B. Husen2, M. Schulz1 and A. Einspanier2

1 Department of Hematology/Oncology, Georg-August-University, Robert-Koch Str. 40, D-37075 Göttingen and 2 Department of Reproductive Biology, German Primate Center, Göttingen, Germany

Until recently, relaxin (RLX) has been known predominantly for its effects on the reproductive system, where it induces remodelling of the extracellular matrix and up-regulation of matrix metalloproteases (MMPs). In solid cancers, tissue remodelling and MMP activation are essential for invasion and metastasis. We therefore investigated the effect of RLX on invasiveness and MMP expression of human breast cancer cell lines. Upon incubation with porcine RLX, the invasiveness of SK-BR3 cells was significantly increased. Similar effects could be achieved in MCF-7 cells, especially when RLX was combined with epidermal growth factor. Enhanced invasiveness was accompanied by up-regulation of MMP production and could be almost completely blocked by the MMP inhibitor FN 439. Zymography revealed increased secretion of MMP-2, -7 and -9, associated with up-regulated mRNA concentrations of MMP-2, -9, -13 and -14. mRNA expression levels of MMP-1, -3, -7, -8, -10, -11, -12 and of tissue inhibitors of metalloproteases-1, -2, -3 and -4 were either very low or not detectably influenced by RLX. Taken together, RLX enhances in-vitro invasiveness of breast cancer cell lines by induction of MMP expression. It remains to be clarified whether RLX might play a similar role in vivo and promote tumour progression.

breast cancer/invasion/matrix metalloproteases/relaxin

3 To whom correspondence should be addressed. E-mail: cbinder{at}med.uni-goettingen.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Ganesh, M. Gonzalez Edick, N. Idamakanti, M. Abramova, M. VanRoey, M. Robinson, C.-O. Yun, and K. Jooss
Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice
Cancer Res., May 1, 2007; 67(9): 4399 - 4407.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T.-Y. Ho, W. Yan, and C. A. Bagnell
Relaxin-induced matrix metalloproteinase-9 expression is associated with activation of the NF-{kappa}B pathway in human THP-1 cells
J. Leukoc. Biol., May 1, 2007; 81(5): 1303 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Feng, I. U. Agoulnik, N. V. Bogatcheva, A. A. Kamat, B. Kwabi-Addo, R. Li, G. Ayala, M. M. Ittmann, and A. I. Agoulnik
Relaxin Promotes Prostate Cancer Progression
Clin. Cancer Res., March 15, 2007; 13(6): 1695 - 1702.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Jeyabalan, J. Novak, K. D. Doty, J. Matthews, M. C. Fisher, L. J. Kerchner, and K. P. Conrad
Vascular Matrix Metalloproteinase-9 Mediates the Inhibition of Myogenic Reactivity in Small Arteries Isolated from Rats after Short-Term Administration of Relaxin
Endocrinology, January 1, 2007; 148(1): 189 - 197.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Hombach-Klonisch, J. Bialek, B. Trojanowicz, E. Weber, H.-J. Holzhausen, J. D. Silvertown, A. J. Summerlee, H. Dralle, C. Hoang-Vu, and T. Klonisch
Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells
Am. J. Pathol., August 1, 2006; 169(2): 617 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox
Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism
J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. T. Nguyen and C. W. Dessauer
Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production
Mol. Endocrinol., April 1, 2005; 19(4): 1012 - 1023.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Hagemann, S. C. Robinson, M. Schulz, L. Trumper, F. R. Balkwill, and C. Binder
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-{alpha} dependent up-regulation of matrix metalloproteases
Carcinogenesis, August 1, 2004; 25(8): 1543 - 1549.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. D. Silvertown, B. J. Geddes, and A. J. S. Summerlee
Adenovirus-Mediated Expression of Human Prorelaxin Promotes the Invasive Potential of Canine Mammary Cancer Cells
Endocrinology, August 1, 2003; 144(8): 3683 - 3691.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.